Cholecystokinin-2 receptor modulates cell adhesion through beta 1-integrin in human pancreatic cancer cells.

Abstract:

:Several lines of evidence suggest that gastrin and the CCK-2 receptor (CCK2R) could contribute to pancreatic carcinogenesis by modulating processes such as proliferation, cell adhesion or migration. In the current study, we used a 'cancer gene array' and identified beta1-integrin subunit as a new gastrin-regulated gene in human pancreatic cancer cells. We also demonstrated that Src family kinases and the phosphatidylinositol-3-kinase (PI-3-kinase) pathway play a crucial role in the expression of beta1-integrin induced by gastrin. Our results also showed that gastrin modulates cell-substrate adhesion via beta1-integrin. Indeed, using blocking anti-beta1-integrin monoclonal antibodies, we completely reversed the increase in cell-substrate adhesion induced by gastrin. In addition, we observed that in response to gastrin, beta1-integrin is tyrosine phosphorylated by Src family kinases and associates with paxillin, a scaffold protein involved in focal adhesion and integrin signalling. This mechanism might be involved in gastrin-induced cell adhesion. Moreover, we showed in vivo that targeted CCK2R expression in the pancreas of Elas-CCK2 mice leads to the overexpression of beta1-integrin. This process may contribute to pancreatic tumour development observed in these transgenic animals.

journal_name

Oncogene

journal_title

Oncogene

authors

Cayrol C,Clerc P,Bertrand C,Gigoux V,Portolan G,Fourmy D,Dufresne M,Seva C

doi

10.1038/sj.onc.1209484

subject

Has Abstract

pub_date

2006-07-27 00:00:00

pages

4421-8

issue

32

eissn

0950-9232

issn

1476-5594

pii

1209484

journal_volume

25

pub_type

杂志文章

相关文献

ONCOGENE文献大全
  • Tumour-suppression function of KLF12 through regulation of anoikis.

    abstract::Suppression of detachment-induced cell death, known as anoikis, is an essential step for cancer metastasis to occur. We report here that expression of KLF12, a member of the Kruppel-like family of transcription factors, is downregulated in lung cancer cell lines that have been selected to grow in the absence of cell a...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2015.394

    authors: Godin-Heymann N,Brabetz S,Murillo MM,Saponaro M,Santos CR,Lobley A,East P,Chakravarty P,Matthews N,Kelly G,Jordan S,Castellano E,Downward J

    更新日期:2016-06-23 00:00:00

  • Deletion mapping implicates two tumor suppressor genes on chromosome 8p in the development of bladder cancer.

    abstract::Chromosome 8 loss of heterozygosity (LOH) in cancer of the urinary bladder is associated with high tumour grade and stage. We have screened 193 cases of transitional cell carcinoma (TCC) of the bladder using 30 microsatellite polymorphisms on chromosome 8. Forty three cases (22%) showed LOH on 8p, the majority of whic...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Takle LA,Knowles MA

    更新日期:1996-03-07 00:00:00

  • Wild-type egr1/Krox24 promotes and dominant-negative mutants inhibit, pluripotent differentiation of p19 embryonal carcinoma cells.

    abstract::The zinc-finger transcription factor Krox24 was analysed for its role in differentiation in P19 embryonal carcinoma cells. Reciprocal dominant negative mutants consisting of Krox24 deleted for a crucial region of the zinc-finger domain (delta Krox24) or of the zinc-finger region alone (delta Krox24Zf) abolished the ac...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202166

    authors: Lanoix J,Mullick A,He Y,Bravo R,Skup D

    更新日期:1998-11-12 00:00:00

  • Nucleic acid targeting: towards personalized therapy for head and neck cancer.

    abstract::In light of a detailed characterization of genetic aberrations in cancer, nucleic acid targeting represents an attractive therapeutic approach with significant translational potential. Head and neck squamous cell carcinoma (HNSCC) is a leading cause of cancer deaths worldwide with stagnant 5-year survival rates. Advan...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/onc.2015.424

    authors: Parsel SM,Grandis JR,Thomas SM

    更新日期:2016-06-23 00:00:00

  • Cyclooxygenase inhibitors differentially modulate p73 isoforms in neuroblastoma.

    abstract::p73 encodes multiple functionally distinct isoforms. Proapoptotic TAp73 isoforms contain a transactivation (TA) domain, and like p53, have tumor suppressor properties and are activated by chemotherapies to induce cell death. In contrast, antiapoptotic DeltaNp73 isoforms lack the TA domain and are dominant-negative inh...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2009.59

    authors: Lau LM,Wolter JK,Lau JT,Cheng LS,Smith KM,Hansford LM,Zhang L,Baruchel S,Robinson F,Irwin MS

    更新日期:2009-05-14 00:00:00

  • Functional inactivation of Cdk9 through oligomerization chain reaction.

    abstract::The oligomerization chain reaction (OCR) strategy is a recently described technique for inactivation of target proteins that function as homoassociate complexes. This novel strategy is based on the fusion of self-associating coiled-coil (CC) domain of the nuclear factor promyelocytic leukemia (PML) to target proteins....

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206785

    authors: Napolitano G,Mazzocco A,Fraldi A,Majello B,Lania L

    更新日期:2003-07-31 00:00:00

  • The membrane-anchored MMP-regulator RECK is a target of myogenic regulatory factors.

    abstract::The membrane-anchored MMP-regulator RECK is down regulated in many solid tumors; the extent of RECK down regulation correlates with poor prognosis. Forced expression of RECK in tumor cells results in suppression of angiogenesis, invasion, and metastasis. Studies on the roles and the mechanisms of regulation of the REC...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208733

    authors: Echizenya M,Kondo S,Takahashi R,Oh J,Kawashima S,Kitayama H,Takahashi C,Noda M

    更新日期:2005-09-01 00:00:00

  • MHC class I dysfunction of glioma stem cells escapes from CTL-mediated immune response via activation of Wnt/β-catenin signaling pathway.

    abstract::Glioma stem cells (GSCs) decrease T cells cognition and evade systemic immunosurveillance via downregulations or defects of major histocompatibility complex class I (MHC-I) molecule and antigen-processing machinery (APM) components. Improvement of tumor surface antigens of GSCs may be effective strategy to trigger an ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-019-1045-6

    authors: Yang W,Li Y,Gao R,Xiu Z,Sun T

    更新日期:2020-01-01 00:00:00

  • From identification of the BTK kinase to effective management of leukemia.

    abstract::BTK is a cytoplasmic protein-tyrosine kinase, whose corresponding gene was isolated in the early 1990s. BTK was initially identified by positional cloning of the gene causing X-linked agammaglobulinemia and independently in a search for new kinases. Given the phenotype of affected patients, namely lack of B-lymphocyte...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/onc.2016.343

    authors: Smith CI

    更新日期:2017-04-01 00:00:00

  • Synergistic functions of E2F7 and E2F8 are critical to suppress stress-induced skin cancer.

    abstract::E2F transcription factors are important regulators of the cell cycle, and unrestrained activation of E2F-dependent transcription is considered to be an important driver of tumor formation and progression. Although highly expressed in normal skin and skin cancer, the role of the atypical E2Fs, E2F7 and E2F8, in keratin...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2016.251

    authors: Thurlings I,Martínez-López LM,Westendorp B,Zijp M,Kuiper R,Tooten P,Kent LN,Leone G,Vos HJ,Burgering B,de Bruin A

    更新日期:2017-02-09 00:00:00

  • Silencing the cochaperone CDC37 destabilizes kinase clients and sensitizes cancer cells to HSP90 inhibitors.

    abstract::The cochaperone CDC37 promotes the association of HSP90 with the protein kinase subset of client proteins to maintain their stability and signalling functions. HSP90 inhibitors induce depletion of clients, which include several oncogenic kinases. We hypothesized that the targeting of CDC37 using siRNAs would compromis...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2008.380

    authors: Smith JR,Clarke PA,de Billy E,Workman P

    更新日期:2009-01-15 00:00:00

  • Casein kinase 2 inhibition sensitizes medulloblastoma to temozolomide.

    abstract::Medulloblastoma (MB) is the most common malignant pediatric brain tumor. Since surviving patients experience severe neurocognitive disabilities, better and more effective treatments are needed to enhance their quality of life. Casein kinase 2 (CK2) is known to regulate cell growth and survival in multiple cancers; how...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-019-0927-y

    authors: Nitta RT,Bolin S,Luo E,Solow-Codero DE,Samghabadi P,Purzner T,Aujla PS,Nwagbo G,Cho YJ,Li G

    更新日期:2019-10-01 00:00:00

  • PP2A-B56α controls oncogene-induced senescence in normal and tumor human melanocytic cells.

    abstract::Oncoprotein C-MYC is overexpressed in human metastatic melanomas and melanoma-derived cells where it is required for the suppression of oncogene-induced senescence (OIS). The genetic events that maintain high levels of C-MYC in melanoma cells and their role in OIS are unknown. Here we report that C-MYC in cells from s...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2011.339

    authors: Mannava S,Omilian AR,Wawrzyniak JA,Fink EE,Zhuang D,Miecznikowski JC,Marshall JR,Soengas MS,Sears RC,Morrison CD,Nikiforov MA

    更新日期:2012-03-22 00:00:00

  • A novel transformation suppressor, Pdcd4, inhibits AP-1 transactivation but not NF-kappaB or ODC transactivation.

    abstract::Pdcd4 is a novel transformation suppressor that is highly expressed in promotion-resistant (P-) mouse epidermal JB6 cells but not in susceptible (P+) cells. Overexpression of pdcd4 cDNA in stably transfected P+ cells rendered cells resistant to tumor promoter-induced transformation, indicating that elevated expression...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1204137

    authors: Yang HS,Jansen AP,Nair R,Shibahara K,Verma AK,Cmarik JL,Colburn NH

    更新日期:2001-02-08 00:00:00

  • Hexokinase II: cancer's double-edged sword acting as both facilitator and gatekeeper of malignancy when bound to mitochondria.

    abstract::A key hallmark of many cancers, particularly the most aggressive, is the capacity to metabolize glucose at an elevated rate, a phenotype detected clinically using positron emission tomography (PET). This phenotype provides cancer cells, including those that participate in metastasis, a distinct competitive edge over n...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1209603

    authors: Mathupala SP,Ko YH,Pedersen PL

    更新日期:2006-08-07 00:00:00

  • Tumor formation in mice with somatic inactivation of the retinoblastoma gene in interphotoreceptor retinol binding protein-expressing cells.

    abstract::The retinoblastoma suppressor gene product Rb has been assigned a critical role in cell cycle regulation, the induction of differentiation, and inhibition of oncogenic transformation. Inheritance of a mutant RB allele in humans is responsible for bilateral retinoblastoma, a malignant tumor of the retina. Trilateral re...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205575

    authors: Vooijs M,te Riele H,van der Valk M,Berns A

    更新日期:2002-07-11 00:00:00

  • Phosphorylation of integrin in differentiating ts-Rous sarcoma virus-infected myogenic cells.

    abstract::The differentiation of primary myogenic cultures requires the attachment of the cells to an extracellular matrix substrate using an integrin family receptor. These integrin receptors can be phosphorylated on both their alpha and beta chains, and it has been postulated that phosphorylation regulates the receptor functi...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Aneskievich BJ,Haimovich B,Boettiger D

    更新日期:1991-08-01 00:00:00

  • Beta-parvin inhibits integrin-linked kinase signaling and is downregulated in breast cancer.

    abstract::We analysed breast tumors and breast cancer cell lines for the expression of beta-parvin (ParvB), an adaptor protein that binds to the integrin-linked kinase (ILK). Quantitative RT-PCR indicated that ParvB mRNA was downregulated, by at least 60%, in four of nine breast tumors, relative to patient-matched normal mammar...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208112

    authors: Mongroo PS,Johnstone CN,Naruszewicz I,Leung-Hagesteijn C,Sung RK,Carnio L,Rustgi AK,Hannigan GE

    更新日期:2004-11-25 00:00:00

  • Activation of Stat5 by platelet-derived growth factor (PDGF) is dependent on phosphorylation sites in PDGF beta-receptor juxtamembrane and kinase insert domains.

    abstract::Signal transducers and activators of transcription (Stats) are known to transduce signals from the cell surface to the nucleus in cytokine receptor signaling. We examined the capacity of platelet-derived growth factor (PDGF) receptor to interact with and activate Stat molecules. Activation of the PDGF beta-receptor le...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201555

    authors: Valgeirsdóttir S,Paukku K,Silvennoinen O,Heldin CH,Claesson-Welsh L

    更新日期:1998-01-29 00:00:00

  • Pim kinase-dependent inhibition of c-Myc degradation.

    abstract::Pim kinases are found to be highly expressed in leukemia, lymphoma, prostate and pancreatic cancer. Bitransgenic mice overexpressing either Pim-1 or Pim-2 and c-Myc succumb to pre-B-cell lymphoma at a strikingly accelerated speed. Despite that Pim-1/Pim-2 has long been recognized as a strong synergistic partner with c...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2008.123

    authors: Zhang Y,Wang Z,Li X,Magnuson NS

    更新日期:2008-08-14 00:00:00

  • FLI-1 inhibits differentiation and induces proliferation of primary erythroblasts.

    abstract::Friend virus-induced erythroleukemia involves two members of the ETS family of transcriptional regulators, both activated via proviral insertion in the corresponding loci. Spi-1/PU.1 is expressed in the disease induced by the original Friend virus SFFV(F-MuLV) complex in adult mice. In contrast, FLI-1 is overexpressed...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202534

    authors: Pereira R,Quang CT,Lesault I,Dolznig H,Beug H,Ghysdael J

    更新日期:1999-02-25 00:00:00

  • Accumulated helix-destabilizing mutations in the leucine zipper of c-Fos leads to attenuation and temperature sensitivity of function.

    abstract::Fos protein heterodimerizes through one surface of an alpha-helical domain called the leucine zipper. We have investigated the effect of destabilizing this domain by multiply substituting small residues of its non-interacting surface with glycine. Ternary complex formation between mutated Fos, Jun and DNA was determin...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Nicklin MJ,Zechner D,Kislyakova T

    更新日期:1993-07-01 00:00:00

  • Tyrosine phosphorylation and complex formation of Cbl-b upon T cell receptor stimulation.

    abstract::Cbl-b, a mammalian homolog of Cbl, consists of an N-terminal region (Cbl-b-N) highly homologous to oncogenic v-Cbl, a Ring finger, and a C-terminal region containing multiple proline-rich stretches and potential tyrosine phosphorylation sites. In the present study, we demonstrate that upon engagement of the T cell rec...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202411

    authors: Elly C,Witte S,Zhang Z,Rosnet O,Lipkowitz S,Altman A,Liu YC

    更新日期:1999-02-04 00:00:00

  • Role of p14ARF-HDM2-p53 axis in SOX6-mediated tumor suppression.

    abstract::Sex-determining region Y box 6 (SOX6) has been described as a tumor-suppressor gene in several cancers. Our previous work has suggested that SOX6 upregulated p21(Waf1/Cip1)(p21) expression in a p53-dependent manner; however, the underlying mechanism has remained elusive. In this study, we confirmed that SOX6 can suppr...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2015.234

    authors: Wang J,Ding S,Duan Z,Xie Q,Zhang T,Zhang X,Wang Y,Chen X,Zhuang H,Lu F

    更新日期:2016-03-31 00:00:00

  • Association of extended in vitro proliferative potential with loss of p16INK4 expression.

    abstract::This study addresses the question of whether loss of p16INK4 expression contributes to the immortalization of human cells. In vitro immortalization usually proceeds through two phases. In the first phase (lifespan extension), cells continue proliferating and their telomeres continue shortening beyond the point at whic...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Noble JR,Rogan EM,Neumann AA,Maclean K,Bryan TM,Reddel RR

    更新日期:1996-09-19 00:00:00

  • The c-Rel transcription factor can both induce and inhibit apoptosis in the same cells via the upregulation of MnSOD.

    abstract::Rel/NF-kappaB transcription factors are involved in several physiological processes, including the regulation of apoptosis. These factors were shown to exhibit pro- or anti-apoptotic activities in different cellular models, but at present, the mechanisms underlying these opposite effects are poorly understood. In this...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205536

    authors: Bernard D,Monte D,Vandenbunder B,Abbadie C

    更新日期:2002-06-27 00:00:00

  • Tumor stroma: a complexity dictated by the hypoxic tumor microenvironment.

    abstract::A lot of effort has been done to study how cancer cells react to low-oxygen tension, a condition known as hypoxia. Indeed, abnormal and dysfunctional blood vessels in the tumor are incapable to restore oxygenation, therefore perpetuating hypoxia, which, in turn, will fuel tumor progression, metastasis and resistance t...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/onc.2013.121

    authors: Casazza A,Di Conza G,Wenes M,Finisguerra V,Deschoemaeker S,Mazzone M

    更新日期:2014-04-03 00:00:00

  • MDM2 protein confers the resistance of a human glioblastoma cell line to cisplatin-induced apoptosis.

    abstract::Induction of apoptosis in tumor cells is an important mechanism of chemotherapy-induced cell death. The tumor-suppressor gene p53 is required for the efficient activation of apoptosis following chemotherapy. However, the molecular mechanism regulating p53-associated apoptosis remains controversial. In this study, we s...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Kondo S,Barnett GH,Hara H,Morimura T,Takeuchi J

    更新日期:1995-05-18 00:00:00

  • SCF-mediated protein degradation and cell cycle control.

    abstract::The regulatory step in ubiquitin (Ub)-mediated protein degradation involves recognition and selection of the target substrate by an E3 Ub-ligase. E3 Ub-ligases evoke sophisticated mechanisms to regulate their activity temporally and spatially, including multiple post-translational modifications, combinatorial E3 Ub-li...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1208614

    authors: Ang XL,Wade Harper J

    更新日期:2005-04-18 00:00:00

  • Interleukin-8 confers androgen-independent growth and migration of LNCaP: differential effects of tyrosine kinases Src and FAK.

    abstract::Interleukin-8 (IL-8), a chemokine implicated in the metastasis and angiogenesis of a variety of cancers, has been reported to be overexpressed in prostate cancer. In this study, we ascribe a new role for IL-8 in prostate cancer progression using LNCaP cells. We demonstrate that IL-8 activates the androgen receptor and...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207344

    authors: Lee LF,Louie MC,Desai SJ,Yang J,Chen HW,Evans CP,Kung HJ

    更新日期:2004-03-18 00:00:00